CDC20 is a novel potential therapeutic target in NF1-mutant melanoma.

e22075Background: NF1-mutant melanoma (NF1-MT) is a distinct molecular subtype with worse overall prognosis than NF1-wild melanoma (NF1-WT). Despite its prevalence in 20% of patients and associated...